Pavadi Capital LLC Laboratory Corp Of America Holdings Transaction History

Pavadi Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$203.72 - $248.97 $578,768 - $707,323	2,841 Added 14.6%	22,297 $5.25 Million
Q3 2022 Nov 14, 2022	SELL	$204.81 - $262.19 $384,428 - $492,130	-1,877 Reduced 8.8%	19,456 $3.99 Million
Q2 2022 Aug 15, 2022	BUY	$213.86 - $277.87 $726,696 - $944,202	3,398 Added 18.95%	21,333 $5 Million
Q1 2022 May 16, 2022	SELL	$259.82 - $298.18 $431,301 - $494,978	-1,660 Reduced 8.47%	17,935 $4.73 Million
Q4 2021 Feb 14, 2022	BUY	$271.6 - $314.21 $5.32 Million - $6.16 Million	19,595 New	19,595 $6.16 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Pavadi Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Pavadi Capital LLC with notifications on news.